Skip to content

A phase II study of ERAS (Enhanced recovery after surgery) protocol in patients undergoing gastrectomy

A phase II study of ERAS (Enhanced recovery after surgery) protocol in patients undergoing gastrectomy - ERAS-GC phase II

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000011619
Enrollment
120
Registered
2013-09-02
Start date
2013-07-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

ERAS protocol

Sponsors

Shizuoka Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Biopsy specimen from the primary lesion shows adenocarcinoma. 2)Curative resection will be performed. Not having esophageal and duodenal invasion 3)Other organ resection is not needed. 4)No limitation in oral intake 5)Epidural anesthesia is allowed. 6)Eastern clinical oncology group performance status is 0. 7)No previous chemotherapy or radiation including those for other cancers. 8)Fulfill all following conditions WBC > 3,000/mm3 Plt > 100,000/mm3 AST < 100 IU/L ALT < 100IU/L T-Bil < 2.0 g/dl Cre < 1.5mg/dl

Exclusion criteria

Exclusion criteria: 1)Having other active cancers 2)With Psychiatric disorder 3)Receiving steroids 4)With acute myocardial infarction in 6 months or with unstable angina 5)With uncontrolled hypertension 6)With uncontrolled diabetes mellitus 7)With some damage after cerebral infarction 8)With pulmonary disease and require continuous oxygen therapy

Design outcomes

Primary

MeasureTime frame
Morbidity

Secondary

MeasureTime frame
Length of postoperative hospital stay Completion rate of ERAS protocol Starting rate of diet at second day after operation Incidence of anastomotic leakage Incidence of postoperative pneumonia Mortality

Countries

Japan

Contacts

Public ContactSugisawa Norihiko

Shizuoka Cancer Center Division of Gastric Surgery

n.sugisawa@scchr.jp055-989-5222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026